C. Gesolfo

Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy

G. Cicero, E. Barresi, V. Serretta, 2018, Urology annals.

Clinical Pitfalls in Diagnosis of Nonmuscle-Invasive Bladder Cancer

V. Serretta, C. Gesolfo, 2015, Urologia.

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy

G. Cicero, V. Franco, V. Serretta, 2015, Urology annals.

Compliance to Therapy with Dapoxetine in Patients Affected by Premature Ejaculation

G. Siracusa, C. Pavone, G. Caruana, 2013, Urologiâ.

MP10-12 COMPARISON BETWEEN THE ASA SCORE AND THE MODIFIED FRAILTY INDEX (MFI) IN UROLOGIC ONCOLOGICAL AND NON ONCOLOGICAL UROLOGICAL INTERVENTIONAL PROCEDURES

V. Serretta, A. Simonato, G. Tulone, 2019, Journal of Urology.

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy

G. Cicero, V. Franco, V. Serretta, 2015, Urology annals.

Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy

G. Cicero, E. Barresi, V. Serretta, 2018, Urology annals.